Dr. Baskar Arumugam presents key results from a clinical trial conducted in China together with co-investigators Drs. Paul Chamberlain, Arthur Bradley, David Hammond, Martin Rickert, Jun Jiang, Xiao Yang and Ruihua We, demonstrating how MiSight 1 day lenses significantly slow the progression of myopia in children. With a high prevalence and faster rates of progression in this population, these findings highlight the role MiSight 1 day plays in effective myopia control.
Learn more about Dr. Arumugam’s insights on these findings here.